H. Brachwitz

493 total citations
38 papers, 414 citations indexed

About

H. Brachwitz is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, H. Brachwitz has authored 38 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Organic Chemistry, 15 papers in Molecular Biology and 5 papers in Infectious Diseases. Recurrent topics in H. Brachwitz's work include Organophosphorus compounds synthesis (11 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and HIV/AIDS drug development and treatment (5 papers). H. Brachwitz is often cited by papers focused on Organophosphorus compounds synthesis (11 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and HIV/AIDS drug development and treatment (5 papers). H. Brachwitz collaborates with scholars based in Germany and Austria. H. Brachwitz's co-authors include P. Langen, J. Bergmann, Florian Überall, I Junghahn, K. Maly, R. Hintsche, G. Etzold, Regine Kraft, H. Grunicke and Christoph Schubert and has published in prestigious journals such as Journal of Lipid Research, Pharmacology & Therapeutics and Bioorganic & Medicinal Chemistry.

In The Last Decade

H. Brachwitz

37 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Brachwitz Germany 12 250 152 55 46 41 38 414
Stanley J. Schmidt United States 12 323 1.3× 193 1.3× 27 0.5× 62 1.3× 28 0.7× 21 546
Mark E. Zupec United States 15 326 1.3× 115 0.8× 43 0.8× 91 2.0× 61 1.5× 18 546
Pauline Chang United States 14 281 1.1× 168 1.1× 27 0.5× 22 0.5× 52 1.3× 31 463
Canio J. Marasco United States 13 390 1.6× 103 0.7× 26 0.5× 27 0.6× 85 2.1× 18 558
Laurence T. Plante United States 11 338 1.4× 89 0.6× 18 0.3× 56 1.2× 44 1.1× 17 464
Henry W. Dion United States 14 388 1.6× 199 1.3× 25 0.5× 47 1.0× 41 1.0× 20 632
Baoxian Wei United States 7 300 1.2× 142 0.9× 26 0.5× 103 2.2× 27 0.7× 8 508
J. A. Stock United Kingdom 11 319 1.3× 222 1.5× 11 0.2× 71 1.5× 47 1.1× 30 583
Terence Beghyn France 11 278 1.1× 120 0.8× 67 1.2× 64 1.4× 33 0.8× 15 465
Hiroko Togame Japan 16 451 1.8× 273 1.8× 26 0.5× 54 1.2× 17 0.4× 25 617

Countries citing papers authored by H. Brachwitz

Since Specialization
Citations

This map shows the geographic impact of H. Brachwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Brachwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Brachwitz more than expected).

Fields of papers citing papers by H. Brachwitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Brachwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Brachwitz. The network helps show where H. Brachwitz may publish in the future.

Co-authorship network of co-authors of H. Brachwitz

This figure shows the co-authorship network connecting the top 25 collaborators of H. Brachwitz. A scholar is included among the top collaborators of H. Brachwitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Brachwitz. H. Brachwitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brachwitz, H., et al.. (1999). Synthesis and antiproliferative potency of 9-β-d-arabinofuranosyl-2-fluoroadenine phospholipid adducts. Bioorganic & Medicinal Chemistry. 7(6). 1195–1200. 8 indexed citations
3.
Brachwitz, H., et al.. (1998). 1-β-d-Arabinofuranosylcytosine-5′-alkylphosphonophosphates and diphosphates: new orally active derivatives of ara-C. Journal of Lipid Research. 39(1). 162–172. 8 indexed citations
4.
Brachwitz, H., et al.. (1997). Alkylphospho-L-serine analogues: Synthesis of cytostatically active alkylphosphono derivatives. Bioorganic & Medicinal Chemistry Letters. 7(13). 1739–1742. 11 indexed citations
5.
Brachwitz, H., et al.. (1997). Synthesis and cytostatical evaluation of cytidine- and adenosine-5′-hexadecylphosphate and their phosphonate analogs. Chemistry and Physics of Lipids. 90(1-2). 143–149. 2 indexed citations
7.
Brachwitz, H., et al.. (1996). Synthesis and antiproliferative activity of cytidine-5′-alkylphosphonophosphates and structurally related compounds. Chemistry and Physics of Lipids. 83(1). 77–85. 8 indexed citations
8.
Grunicke, H., et al.. (1996). Cellular signalling as a target in cancer chemotherapy. Phospholipid analogues as inhibitors of mitogenic signal transduction. Advances in Enzyme Regulation. 36. 385–407. 16 indexed citations
9.
Junghahn, I, et al.. (1995). Effect of ALP analogs on inositol trisphosphate formation in H184 mammary epithelial cells before and after transfection with v-erb B oncogene.. PubMed. 15(2). 449–54. 7 indexed citations
10.
Grunicke, H., et al.. (1995). Interference of new alkylphospholipid analogues with mitogenic signal transduction. Journal of Cancer Research and Clinical Oncology. 121(S1). A1–A1. 17 indexed citations
11.
Brachwitz, H., et al.. (1995). Analogs of alkyllysophospholipids: Chemistry, effects on the molecular level and their consequences for normal and malignant cells. Pharmacology & Therapeutics. 66(1). 39–82. 85 indexed citations
12.
Brachwitz, H., et al.. (1990). Halo lipids. 10. Synthesis and cytostatic activity of O-alkylglycerophospho-l-serine analogs. Chemistry and Physics of Lipids. 54(2). 89–98. 18 indexed citations
13.
Zeisig, Reiner, et al.. (1990). [Ether lipids--synthesis and application in tumor therapy].. PubMed. 45(11). 809–18. 5 indexed citations
14.
Matthes, Eckart, P. Langen, H. Brachwitz, et al.. (1990). Alteration of DNA topoisomerase II activity during infection of H9 cells by human immunodeficiency virus type 1 in vitro: A target for potential therapeutic agents. Antiviral Research. 13(6). 273–286. 18 indexed citations
15.
Brachwitz, H., et al.. (1984). Halo lipids. VI. Stimulation of human and rabbit blood platelets by racemic halo analogues of O-alkyl-glycerophosphocholine.. PubMed. 43(3). 349–55. 1 indexed citations
16.
Brachwitz, H., et al.. (1984). Halo lipids. 7. Synthesis of rac 1-chloro-1-deoxy-2-O-hexadecylglycero-3-phosphocholine. Chemistry and Physics of Lipids. 34(4). 355–362. 9 indexed citations
17.
Brachwitz, H., et al.. (1980). ChemInform Abstract: HALOLIPIDS. III. ALKYL GLYCERYL ETHER ANALOGS. Chemischer Informationsdienst. 11(2). 1 indexed citations
18.
Kraft, Regine, et al.. (1979). Halogenlipide. I. Massenspektrometrische Strukturuntersuchung stellungsisomerer Fettsäureester der Halogenpropandiole (Desoxyhalogen‐glyceride). Journal für praktische Chemie. 321(5). 756–768. 23 indexed citations
19.
Brachwitz, H.. (1972). Hydroximsäurederivate. VI. 1,2,4‐Oxadiazole aus N‐Acylamino‐acetonitrilen. Journal für praktische Chemie. 314(3-4). 447–454. 1 indexed citations
20.
Brachwitz, H.. (1969). Hydroximsäurederivate II. Versuche zur Darstellung von 3‐Benzoyl‐1.2.4‐oxadiazolen. Journal für praktische Chemie. 311(4). 661–670. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026